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Background
We have previously shown that this cohort of exposed
uninfected individuals (EU) of men who have sex with
men (MSM) display HIV-1 neutralizing capacity in their
salivary IgA1 (AIDS 2009). To investigate whether oral
HIV-1 exposure mounts also a systemic anti-HIV-1
response, we have here investigated consecutive samples
of plasma (unfractioned and IgA1 purified) for neutraliz-
ing capacity, and whether the response correlates with
exposure measured by viral load in the HIV-positive part-
ners.
Methods
Plasma were collected from EU (n = 25) every 6 months
during 2 years and from low-risk controls (n = 22). IgA1-
purification was performed with jacaline. Neutralization
was tested in a PBMC-based neutralization assay using
three primary HIV-1 isolates. Self-reported questionnaires
described routes of HIV-1-exposure, and clinical records
determined viral load in HIV-positive partners.
Results
At study start, plasma samples from 7/25 EU could neu-
tralize 2 of 3 tested HIV-1 isolates. None of the 22 low-risk
controls could neutralize any HIV-1 isolate (p = 0.01). 6/
7 EU retained their neutralization capacity during contin-
uous exposure, although 3/6 EU only neutralized one of
the three HIV-1 isolates at time of last sampling. Of
importance, the neutralization capacity among EU corre-
lated with a significantly higher viral load in the respective
partners compared to partners of non-neutralizing EU.
Purified IgA1 was shown to mediate neutralization in 6/7
samples whereas none of the IgA1-depleted plasma sam-
ples could neutralize HIV-1.
Conclusion
Orally exposed uninfected MSM can mount an anti-HIV-
1 response in plasma, here shown to correlate with the
viral load in the HIV-positive partner.
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